Park, S., Ha, S., Lee, S., Paeng, J. C., Keam, B., Kim, T. M., . . . Heo, D. S. (2018). Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor. PLoS One.

Park, Sehhoon, Seunggyun Ha, Se-Hoon Lee, Jin Chul Paeng, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, et Dae Seog Heo. "Intratumoral Heterogeneity Characterized By Pretreatment PET in Non-small Cell Lung Cancer Patients Predicts Progression-free Survival On EGFR Tyrosine Kinase Inhibitor." PLoS One 2018.

Park, Sehhoon, et al. "Intratumoral Heterogeneity Characterized By Pretreatment PET in Non-small Cell Lung Cancer Patients Predicts Progression-free Survival On EGFR Tyrosine Kinase Inhibitor." PLoS One 2018.